Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessphosphatidylinositol-mediated signaling

PI4KA PLCB2 FGFR1

2.46e-0524493GO:0048015
GeneOntologyBiologicalProcesssiRNA-mediated post-transcriptional gene silencing

AGO4 AGO3

3.31e-054492GO:0140766
GeneOntologyBiologicalProcesssiRNA-mediated gene silencing by mRNA destabilization

AGO4 AGO3

3.31e-054492GO:0090625
GeneOntologyCellularComponentRISC-loading complex

AGO4 AGO3

2.49e-0410502GO:0070578
DomainBAT2_N

PRRC2C PRRC2B

2.19e-053512PF07001
DomainBAT2_N

PRRC2C PRRC2B

2.19e-053512IPR009738
DomainPRRC2

PRRC2C PRRC2B

2.19e-053512IPR033184
DomainArgonaute_N

AGO4 AGO3

4.37e-054512IPR032474
DomainArgonaute_Mid_dom

AGO4 AGO3

4.37e-054512IPR032473
DomainArgoL2

AGO4 AGO3

4.37e-054512IPR032472
DomainArgoN

AGO4 AGO3

4.37e-054512PF16486
DomainArgoMid

AGO4 AGO3

4.37e-054512PF16487
DomainArgoL2

AGO4 AGO3

4.37e-054512PF16488
DomainFerI

OTOF FER1L6

7.27e-055512SM01202
DomainFerB

OTOF FER1L6

7.27e-055512SM01201
DomainFerlin_B-domain

OTOF FER1L6

7.27e-055512IPR012561
DomainFerlin_C

OTOF FER1L6

7.27e-055512PF16165
DomainFerlin_C

OTOF FER1L6

7.27e-055512IPR032362
DomainFerIin_dom

OTOF FER1L6

7.27e-055512IPR012968
DomainFerI

OTOF FER1L6

7.27e-055512PF08151
DomainFerB

OTOF FER1L6

7.27e-055512PF08150
DomainDUF1785

AGO4 AGO3

7.27e-055512SM01163
DomainArgoL1

AGO4 AGO3

1.09e-046512PF08699
DomainVal/Leu/Ile-tRNA-synth_edit

IARS2 LARS2

1.09e-046512IPR009008
DomainArgoL1

AGO4 AGO3

1.09e-046512IPR014811
DomainAnticodon_1

IARS2 LARS2

1.09e-046512PF08264
DomainM/V/L/I-tRNA-synth_anticd-bd

IARS2 LARS2

1.09e-046512IPR013155
Domain-

IARS2 LARS2

1.09e-0465123.90.740.10
Domainaa-tRNA-synth_Ia

IARS2 LARS2

1.52e-047512IPR002300
DomaintRNA-synt_1

IARS2 LARS2

1.52e-047512PF00133
DomainPIWI

AGO4 AGO3

2.03e-048512PS50822
DomainPiwi

AGO4 AGO3

2.03e-048512SM00950
DomainPiwi

AGO4 AGO3

2.03e-048512IPR003165
DomainPiwi

AGO4 AGO3

2.03e-048512PF02171
DomainPAZ

AGO4 AGO3

2.60e-049512PS50821
DomainPAZ

AGO4 AGO3

2.60e-049512SM00949
DomainPAZ_dom

AGO4 AGO3

2.60e-049512IPR003100
DomainPAZ

AGO4 AGO3

2.60e-049512PF02170
Domain-

REXO2 AGO4 AGO3

2.86e-04475133.30.420.10
Domain-

IARS2 LARS2

3.96e-04115121.10.730.10
DomainC2

OTOF PRKCE PLCB2 FER1L6

4.48e-04131514PF00168
DomainC2

OTOF PRKCE PLCB2 FER1L6

5.30e-04137514SM00239
DomainC2

OTOF PRKCE PLCB2 FER1L6

6.07e-04142514PS50004
Domain-

OTOF PRKCE PLCB2 FER1L6

7.08e-041485142.60.40.150
DomaintRNAsynth_Ia_anticodon-bd

IARS2 LARS2

7.50e-0415512IPR009080
DomainRNaseH-like_dom

REXO2 AGO4 AGO3

8.85e-0469513IPR012337
DomainC2_dom

OTOF PRKCE PLCB2 FER1L6

1.04e-03164514IPR000008
Domainaa-tRNA-synth_I_CS

IARS2 LARS2

1.09e-0318512IPR001412
DomainAA_TRNA_LIGASE_I

IARS2 LARS2

1.21e-0319512PS00178
PathwayBIOCARTA_DICER_PATHWAY

AGO4 AGO3

5.96e-055352M22079
PathwayREACTOME_MICRORNA_MIRNA_BIOGENESIS

AGO4 AGO3

8.93e-056352MM14818
PathwayREACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS

AGO4 AGO3

8.93e-056352MM15083
PathwayREACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS

AGO4 AGO3

1.25e-047352M46421
PathwayREACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS

AGO4 AGO3

1.66e-048352MM15082
PathwayREACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS

AGO4 AGO3

2.13e-049352M27340
PathwayREACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION

AGO4 AGO3

2.13e-049352M27810
PathwayREACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION

AGO4 AGO3

2.13e-049352M46436
PathwayREACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS

AGO4 AGO3

2.66e-0410352M48013
PathwayKEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS

IARS2 LARS2

3.25e-0411352M17946
PathwayREACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION

AGO4 AGO3

4.59e-0413352M46434
PathwayREACTOME_CA2_PATHWAY

AGO4 AGO3 PLCB2

4.80e-0462353M27321
PathwayREACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY

AGO4 AGO3

7.96e-0417352M27788
PathwayREACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS

AGO4 AGO3 CD80 PRKCE FGFR1

9.82e-04313355M27867
PathwayREACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS

AGO4 AGO3

9.97e-0419352M48238
PathwayREACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION

IARS2 LARS2

1.22e-0321352M15096
Pubmed

Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells.

PRKCE TOP2A

6.32e-06351235247890
Pubmed

Phosphorylation of serine 779 in fibroblast growth factor receptor 1 and 2 by protein kinase C(epsilon) regulates Ras/mitogen-activated protein kinase signaling and neuronal differentiation.

PRKCE FGFR1

6.32e-06351223564461
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

BCL9L PRRC2C GLYR1 LARS2 TOP2A PRRC2B

9.07e-0633251637433992
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

AGO3 PRRC2C PI4KA SPHKAP GLUL PRKCE GOLGA2 CYFIP2 PRRC2B

9.87e-0696351928671696
Pubmed

Argonaute proteins: potential biomarkers for human colon cancer.

AGO4 AGO3

1.26e-05451220146808
Pubmed

Molecular dissection of human Argonaute proteins by DNA shuffling.

AGO4 AGO3

1.26e-05451223748378
Pubmed

Slicing-independent RISC activation requires the argonaute PAZ domain.

AGO4 AGO3

1.26e-05451222795694
Pubmed

Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.

AGO4 AGO3

1.26e-05451215260970
Pubmed

ATP-dependent human RISC assembly pathways.

AGO4 AGO3

1.26e-05451219966796
Pubmed

Importance of translation and nonnucleolytic ago proteins for on-target RNA interference.

AGO4 AGO3

1.26e-05451218771919
Pubmed

A Requirement for Argonaute 4 in Mammalian Antiviral Defense.

AGO4 AGO3

1.26e-05451232049003
Pubmed

Short-interfering-RNA-mediated gene silencing in mammalian cells requires Dicer and eIF2C translation initiation factors.

AGO4 AGO3

2.10e-05551212526743
Pubmed

Differential expression of Dicer and Argonaute genes during the differentiation of human neuroblastoma cells.

AGO4 AGO3

2.10e-05551219393748
Pubmed

The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing.

AGO4 AGO3

2.10e-05551219324964
Pubmed

Differential expression of components of the microRNA machinery during mouse organogenesis.

AGO4 AGO3

2.10e-05551216036130
Pubmed

The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis.

AGO4 AGO3

2.10e-05551212414724
Pubmed

An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia.

PI4KA FGFR1

3.15e-05651217893707
Pubmed

Genome-wide identification of microRNA targets reveals positive regulation of the Hippo pathway by miR-122 during liver development.

AGO4 AGO3

4.41e-05751234907157
Pubmed

Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps.

AGO4 AGO3

4.41e-05751219536157
Pubmed

The C-terminal domains of human TNRC6A, TNRC6B, and TNRC6C silence bound transcripts independently of Argonaute proteins.

AGO4 AGO3

4.41e-05751219383768
Pubmed

Functional dissection of the human TNRC6 (GW182-related) family of proteins.

AGO4 AGO3

4.41e-05751219470757
Pubmed

AGO4 regulates entry into meiosis and influences silencing of sex chromosomes in the male mouse germline.

AGO4 AGO3

4.41e-05751222863743
Pubmed

Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis.

AGO4 AGO3

5.87e-05851219345100
Pubmed

Suppression of microRNA Activity in Kidney Collecting Ducts Induces Partial Loss of Epithelial Phenotype and Renal Fibrosis.

AGO4 AGO3

5.87e-05851229021386
Pubmed

ATG5 is required for B cell polarization and presentation of particulate antigens.

DOCK2 PRRC2C GOLGA2 TOP2A CYFIP2 PRRC2B CLASRP

7.03e-0570151730196744
Pubmed

Identification of eight members of the Argonaute family in the human genome.

AGO4 AGO3

7.54e-05951212906857
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

IVNS1ABP GGA2 AGO4 NBEAL2 MED12L LRRK1

1.21e-0452951614621295
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

BCL9L OTOF PRRC2C PRRC2B CLASRP

1.86e-0436151526167880
Pubmed

Protein kinase Cε modulates insulin receptor localization and trafficking in mouse embryonic fibroblasts.

PSG11 PRKCE

1.90e-041451223469261
Pubmed

TRIM24 is an insulin-responsive regulator of P-bodies.

AGO4 AGO3 TOP2A

2.25e-048051335803934
Pubmed

Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon.

IVNS1ABP GLUL PIH1D1

2.34e-048151326990986
Pubmed

Tooth morphogenesis and ameloblast differentiation are regulated by micro-RNAs.

AGO4 AGO3

2.50e-041651220102707
Pubmed

LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization.

PRRC2C TOP2A

2.83e-041751237072811
Pubmed

The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.

HEATR6 PI4KA GOLGA2 TOP2A

3.65e-0423051435449600
Pubmed

Dynamics of the rhomboid-like protein RHBDD2 expression in mouse retina and involvement of its human ortholog in retinitis pigmentosa.

GLUL GOLGA2

4.35e-042151223386608
Pubmed

Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

AGO4 AGO3 MED12L

4.47e-0410151310997877
Pubmed

PRRC2B modulates oligodendrocyte progenitor cell development and myelination by stabilizing Sox2 mRNA.

PRRC2C PRRC2B

4.78e-042251238507412
Pubmed

Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages.

PRKCE PLCB2

5.70e-042451210843712
Pubmed

Gestational stress induces the unfolded protein response, resulting in heart defects.

FGFR1 GOLGA2

6.19e-042551227436040
Pubmed

The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.

GGA2 GLUL PRXL2A ZDHHC17 PIH1D1 GOLGA2 PRRC2B

6.37e-04100751734597346
Pubmed

Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade.

PRKCE PLCB2

7.23e-042751220336759
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

PI4KA GLUL PRKCE CYFIP2

7.73e-0428151428706196
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

IARS2 PI4KA GHITM ZDHHC17 PIH1D1 LARS2 TOP2A PRRC2B

1.41e-03149651832877691
Pubmed

Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha.

PRKCE PLCB2

1.43e-033851212482669
InteractionFKBP5 interactions

IARS2 AGO4 AGO3 PRRC2C PI4KA LRRK1 PIH1D1 TOP2A

6.40e-06414498int:FKBP5
Cytoband10q23.1

GHITM PRXL2A

3.02e-042351210q23.1
Cytoband1p34

AGO4 AGO3

5.87e-04325121p34
CytobandEnsembl 112 genes in cytogenetic band chr1q25

IVNS1ABP RALGPS2 GLUL

8.66e-04167513chr1q25
GeneFamilyFerlin family

OTOF FER1L6

5.43e-056352828
GeneFamilyArgonaute/PIWI family

AGO4 AGO3

1.01e-048352408
GeneFamilyAminoacyl tRNA synthetases, Class I

IARS2 LARS2

6.10e-0419352131
GeneFamilyAdenosine receptors|V-set domain containing

CD80 PSG11 VSTM2A

3.81e-03163353590
ToppCellImmune-dendritic_cell|World / Lineage, Cell type, age group and donor

DOCK2 CD80 MED12L LRRK1 CYFIP2

1.53e-061715156a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea
ToppCellAdult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor

IVNS1ABP DOCK2 SLC9A9 SLC39A12 GLUL

2.24e-06185515ab5704b96f1d368911308797d10c7c52766ab134
ToppCellAdult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor

DOCK2 SLC9A9 CD80 PLCB2 LRRK1

2.62e-06191515cbebb4d9550fdcd606cb3685ac9546c6b73fd422
ToppCellhuman_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)

DOCK2 SLC9A9 CD80 PLCB2 LRRK1

2.90e-06195515ba7f85e5307d96ac5ad7c952f8d094db9ca1790c
ToppCellLPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

DOCK2 SLC9A9 GGA2 CD80 PLCB2

3.13e-06198515e8002972410e4803d85263ba2642e6855cef83e9
ToppCellFetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DOCK2 CD80 MED12L CYFIP2

2.99e-051555149f937ae48767fdcf1a944af4de0530d9c0ab441d
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 CD80 PLCB2 TOP2A

3.38e-05160514cfd005e98944817458e8ef9e0c436d77f50c1ad1
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9

AGO4 AGO3 MED12L PLCB2

3.55e-05162514810881210e015c788814e4fe8d7a24c929cf2621
ToppCelldroplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GHITM GLUL PRXL2A ACMSD

3.72e-05164514f9a2cc12179d5621c9174ec01d7418a71edd28d1
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

4.58e-0517351473f858f2c45d19b9ec8d99ac02c91551790f670c
ToppCellfacs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 PLCB2 TOP2A CYFIP2

4.58e-05173514513b4d31bcfb269556c6b4cc389865fb12e52c4f
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GGA2 CD80 RALGPS2 PRXL2A

4.79e-0517551487e557f7508c88b2087db5d57e77d5e2c92ca083
ToppCellFetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DOCK2 CD80 MED12L LRRK1

5.01e-05177514c5e829bc4594761666d65cace5a9c5d19c16f187
ToppCellLPS-antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK2 CD80 GLUL ATP9B

5.12e-05178514289d1425c4e57fabcca994b27f9af1c0ce5d5bec
ToppCellControl-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations)

DOCK2 CD80 GLUL MED12L

5.35e-0518051425ad95c3c30e3b82abe93bd77ba003f5c2241f7c
ToppCellfacs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 PLCB2 TOP2A CYFIP2

5.58e-05182514df26388c0c46d1c4775103c8e802937b4d4e7470
ToppCellCOVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations)

DOCK2 CD80 MED12L LRRK1

5.70e-05183514703364836b42aa6ac6c68b42b700ac23c4a1afc7
ToppCellfacs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 PLCB2 TOP2A CYFIP2

5.70e-05183514062ec08d66c923f90fee771b1bf8d98bdc7e6c1b
ToppCellCOVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations)

DOCK2 CD80 MED12L LRRK1

5.70e-05183514b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9
ToppCellfacs-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IVNS1ABP NBEAL2 RALGPS2 CYFIP2

5.82e-05184514dc7f6ee4062856a02423fff8b1cce62d46a9355c
ToppCellIPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class

CD80 MED12L LRRK1 CYFIP2

5.95e-05185514f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464
ToppCellIPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class

CD80 MED12L LRRK1 CYFIP2

5.95e-05185514ced17f69486591c3cbbdc852a3e82c3f3a4a30d7
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 NBEAL2 LRRK1

6.07e-05186514305f1726b8b5add32f1c29c74991ff34f42e0da7
ToppCellCOVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK2 RALGPS2 LRRK1 TOP2A

6.33e-05188514567b08514d9d84cbb40f9b7a679eec304f023428
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

6.59e-05190514788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IVNS1ABP MED12L SLC28A3 TOP2A

6.73e-051915146c1283d51a845cff67ed5e500f7e944165297b53
ToppCellhuman_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells)

DOCK2 SLC9A9 CD80 LRRK1

6.73e-051915143b59bfc6c106ae8a3fbcd4a74bd128c485724921
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

6.73e-05191514baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCellfacs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GGA2 RALGPS2 PRKCE LARS2

6.87e-051925142de242d81dc085ae734eb7d1f091af9a542e0866
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

IVNS1ABP MED12L SLC28A3 TOP2A

6.87e-0519251486d561c30554ff04c21801d4aaf8e3c9efe49af4
ToppCellCOVID-19_Severe-Myeloid_G-immature_Neutrophil|COVID-19_Severe / Disease group, lineage and cell class

IVNS1ABP MED12L SLC28A3 TOP2A

6.87e-05192514303deb68da2e4a75e6ee5a79478182a8bc41c7c5
ToppCellH1299-infected|H1299 / Cell line, Condition and Strain

PRRC2C GOLGA2 TOP2A PRRC2B

6.87e-051925149cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCellfacs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GGA2 RALGPS2 PRKCE LARS2

6.87e-05192514ba2a683472a8b785dbf666dc6e94356d879486c3
ToppCellAdult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor

IVNS1ABP DOCK2 CD80 GLUL

6.87e-05192514733491e932350e3c216a626cc49c3cd3fe970a82
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

7.01e-051935143e3d7cb3e7242ec9c9677e07e303835649852b52
ToppCellFetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DOCK2 SLC9A9 GLUL PLCB2

7.01e-051935142d0dd2671ff27b922eb316f1ed0140353536ef30
ToppCellSmart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

IVNS1ABP NBEAL2 GLUL PLCB2

7.29e-05195514ae98215b7b7f22f1aca690920ce6092dc4a3c7db
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

7.29e-051955142d485373bfd9bb4bb9236bf0b31d03e132c8018f
ToppCellChildren_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

IVNS1ABP DOCK2 GLUL PRKCE

7.29e-051955149d649ac7d2af313481069c95349efc0c68449e2b
ToppCell(3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis

SPHKAP GLUL FGFR1 LRRK1

7.29e-05195514f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff
ToppCellSmart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

IVNS1ABP NBEAL2 GLUL PLCB2

7.29e-051955146fcab7aa4db958ccad0300adea9aaae52ace5bff
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

7.29e-05195514ce8215d503cad3a9bc7d5d2be4adb57408015593
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

7.29e-0519551409df40ff9b493170861b3f6e57a942a834655b5c
ToppCellfacs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRRC2C GLUL FGFR1 LARS2

7.29e-05195514c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IVNS1ABP PRRC2C FGFR1 LARS2

7.44e-0519651466d76249bd2770cdddff2c1fe59a016e95da2124
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

7.44e-051965144370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IVNS1ABP PRRC2C FGFR1 LARS2

7.44e-051965149bd4c146fc7555e32adfa393b3a07846eb826d25
ToppCellfacs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IVNS1ABP PRRC2C GLUL FGFR1

7.44e-0519651497ac47daf5bb07fa5dda3976e1ae402750f959b5
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_B-Memory_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue

GGA2 CD80 RALGPS2 LRRK1

7.44e-05196514c450cd6b799932f5cce8326d1079114abeb71e95
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IVNS1ABP PRRC2C FGFR1 LARS2

7.44e-05196514151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCellmild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

MED12L PRXL2A LRRK1 ZDHHC17

7.58e-051975140cb00daa6943f7a7fb34a8fdf51188646af65686
ToppCellCOVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type

DOCK2 OTOF GLUL PLCB2

7.58e-05197514a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCellBronchial-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 CD80 PLCB2 LRRK1

7.58e-05197514e0fc098bfb5a8b7824ae339f3adda30f78360d0b
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

7.58e-05197514d95565652ca318a2298d6918d54ba6367e9560f4
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

7.58e-0519751457dafb3047745a44b2345b8036e159c3641d496e
ToppCellCOVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK2 OTOF GLUL PLCB2

7.73e-05198514ea34096bee852a7e996f097fa279381afa8f86ff
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

7.73e-0519851496883ad8e189a46ed5b7eaafc0543e53682d26ed
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 CD80 RALGPS2 CYFIP2

7.73e-05198514824461cf44098440ba8bc0df96735423ac65bda1
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 CD80 RALGPS2 CYFIP2

7.73e-05198514863765ccc0205dc28864dae85af339c283194c96
ToppCellSepsis-ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, condition lineage and cell class

ABCA6 MED12L PRXL2A ZDHHC17

7.73e-05198514fe8a68bff8c1b9566eee4bfcab564f206a20ae7b
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 SLC9A9 PLCB2 LRRK1

7.89e-0519951404adf46975aa4194ea40c7480f8a517def5d929c
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 SLC9A9 SLC39A12 PLCB2

8.04e-05200514179afc4bee7a2fd85a3b5dadf32544a63807c164
ToppCellCOVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class

IVNS1ABP MED12L SLC28A3 TOP2A

8.04e-05200514cbe667eda1af222467df8bfa157aa22df488f133
ToppCellHematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

DOCK2 SLC9A9 MED12L LRRK1

8.04e-05200514a20dce14f94777687aad57d6fbe3258ad376f63f
ToppCellHematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

DOCK2 SLC9A9 MED12L LRRK1

8.04e-05200514dc344b3ec51d506952e38f0b3a7795d65f9dd4eb
ToppCellHematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

DOCK2 SLC9A9 MED12L LRRK1

8.04e-052005143bba5219453322198e8fdb0921d5f8c403598751
ToppCellmild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

GGA2 CD80 RALGPS2 PRKCE

8.04e-05200514fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCellHematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

DOCK2 SLC9A9 MED12L LRRK1

8.04e-0520051421bcca3b670fe9bac034aef2275d3de4a9a73e2b
ToppCellHematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

DOCK2 SLC9A9 MED12L LRRK1

8.04e-05200514a8646d0fca99f10827c2d2a12e584660ef7155f1
ToppCellHematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic

DOCK2 SLC9A9 MED12L LRRK1

8.04e-0520051433036d21c1c82109284473a515c4f890b33fdd5c
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Lypd1_(CA1_Principal_cells_(Anterior))|Hippocampus / BrainAtlas - Mouse McCarroll V32

SPINK8 CYP21A2 ALOX12B

1.23e-048451352d167614afa9b056f2934142d3250fe5e70e806
ToppCellThalamus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--|Thalamus / BrainAtlas - Mouse McCarroll V32

GARIN4 CD80 PLCB2

2.94e-04113513f606c2003ce9b17f3c27a7c24ee6bf30f28a2b06
ToppCellThalamus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)|Thalamus / BrainAtlas - Mouse McCarroll V32

GARIN4 CD80 PLCB2

2.94e-041135139b239bfa00aa2d2e27d13d80fe54ef4f2fea49c0
ToppCellThalamus-Hematopoietic-MICROGLIA|Thalamus / BrainAtlas - Mouse McCarroll V32

GARIN4 CD80 PLCB2

2.94e-04113513b82c5dd560a0e309f2b79ca874b006f914baade7
ToppCellThalamus-Hematopoietic-MICROGLIA-MI2(C1qb)|Thalamus / BrainAtlas - Mouse McCarroll V32

GARIN4 CD80 PLCB2

2.94e-04113513d5e6f36d2d6afaadfbf60b56c16ed15775139ed4
ToppCellThalamus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-|Thalamus / BrainAtlas - Mouse McCarroll V32

GARIN4 CD80 PLCB2

2.94e-04113513a339ddee70054612afef3cc9dc156738202af4cd
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ABCA6 ACMSD FER1L6

4.85e-0413451364979e1a056b7406e1be39c5ebe2f8d731ac3c17
ToppCellRV-14._Fibroblast_III|World / Chamber and Cluster_Paper

SLC9A9 ABCA6 CD80

4.85e-041345138c4046ba1f85172915a112499e492c3efe8474c2
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9

AGO4 AGO3 CYP21A2

4.95e-041355133351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SPINK8 FGFR1 ALOX12B

5.06e-041365131f3000d5f105c87c80f8ae1dd2264bcd7f757a9c
ToppCellRV-14._Fibroblast_III|RV / Chamber and Cluster_Paper

SLC9A9 ABCA6 CD80

5.50e-04140513b4fee8eb6bf855b364b00bda3f78e49d851bbca0
ToppCelldroplet-Heart-nan-3m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MED12L PRXL2A PLCB2

5.50e-04140513ab90f6f30d89761687f8836e3d327d143ce49ed4
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SLC9A9 OTOF ALOX12B

5.74e-04142513d08e1880425d285c4433014fe0242ac7ff7734af
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ABCA6 ACMSD FER1L6

5.74e-041425135690eee2ce1ecd02e34eac4193578bd13c4228b9
ToppCellLPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK2 SLC9A9 CD80

6.22e-04146513b76110b159acd27a2c8d6a9f98336608ace1ec12
ToppCellHealthy-B_cell|World / disease group, cell group and cell class

ABCA6 RALGPS2 ALOX12B

6.22e-04146513588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 PLCB2 LRRK1

6.47e-0414851312fa2c4922f03803006c606b1b16e79441e3bb13
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SLC9A9 OTOF ALOX12B

6.47e-04148513d5cace5605bff2bb8248fadb51f2dad7539930ba
ToppCellSubstantia_nigra-Hematopoietic-MICROGLIA|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

DOCK2 PLCB2 TOP2A

6.73e-04150513d44c02402e59a45e40b8fffbe71284032b5e7c92
ToppCellSubstantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

DOCK2 PLCB2 TOP2A

6.73e-04150513e020dbcf85c0ba7ad667b8bbeb6bbcfc135c9bb7
ToppCellSubstantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

DOCK2 PLCB2 TOP2A

6.73e-04150513edbc1d29d213bf5908592135700e0d80e123c923
ToppCellSubstantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

DOCK2 PLCB2 TOP2A

6.73e-0415051301c526e1e3007e71e416c317549fddd2919b14e9
ToppCellSubstantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

DOCK2 PLCB2 TOP2A

6.73e-04150513b7f5bf9af7ed50aad4da1c71d37b8b9709e6ce85
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue

GGA2 ABCA6 MED12L

6.99e-041525134f690aed23338687bdefc47e8a2f3d1fdb2b6447
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 PLCB2 TOP2A

6.99e-04152513bfc7ef4ee26165d18ac4f475a9519e8d52453ba2
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 PLCB2 TOP2A

7.26e-04154513ee03b386d28a524084eaf1c0091f7389daa34250
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 PLCB2 TOP2A

7.26e-041545133fa6f77ad2c30ec24b9b904e2732ec5b419dff5b
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRKCE LARS2 CYFIP2

7.40e-0415551372a19a9ecfd13f6769c4b447d3ce01a855ec6ec7
ToppCellCOVID-19-Myeloid-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations)

DOCK2 CD80 GLUL

7.54e-04156513a07a9096799e4ba663841c70035b4b32c1fda4f9
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

IVNS1ABP ABCA6 ATP9B

7.54e-041565134d2679e7639758c49fc25a2deb9109b08f0a3e57
ComputationalGenes in the cancer module 484.

DOCK2 NBEAL2 CYFIP2

1.70e-0442283MODULE_484
ComputationalGenes in the cancer module 430.

DOCK2 NBEAL2 CYFIP2

3.79e-0455283MODULE_430
Diseaselimb-girdle muscular dystrophy (implicated_via_orthology)

OTOF FER1L6

5.88e-057502DOID:11724 (implicated_via_orthology)
Diseaseobesity (implicated_via_orthology)

ABHD4 GLUL MED12L PLCB2

4.85e-04215504DOID:9970 (implicated_via_orthology)
Diseasealbuminuria

PRRC2C SPHKAP CYP21A2

5.51e-0494503EFO_0004285
Diseasesunburn

PRXL2A PRKCE FGFR1

5.85e-0496503EFO_0003958
DiseaseFEV change measurement, response to zileuton

CYP21A2 PRKCE

8.23e-0425502EFO_0005921, EFO_0007676
Diseasetotal blood protein measurement

ABCA6 CYP21A2 SLC28A3 FGFR1 LRRK1

9.62e-04449505EFO_0004536
Diseasemitochondrial metabolism disease (implicated_via_orthology)

IARS2 LARS2

1.62e-0335502DOID:700 (implicated_via_orthology)
Diseasehigh grade glioma (implicated_via_orthology)

CD80 FGFR1

2.54e-0344502DOID:3070 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
AVSDMGLWRMQVFAM

ABCA6

826

Q8N139
FKAMMESFGWARRPM

ABHD4

256

Q8TB40
LFVHPWDMQMDGRMA

ACMSD

171

Q8TDX5
FGFHQSVRPAMWKMM

AGO3

201

Q9H9G7
GFHQSVRPAMWNMML

AGO4

191

Q9HCK5
VRPAMWNMMLNIDVS

AGO4

196

Q9HCK5
MMSGDMNIWPEYKNR

CD80

76

P33681
SGVPVSMLQTAWMMA

OR10A7

151

Q8NGE5
MPANSNLRWDPDFMM

MED12L

966

Q86YW9
WKMMGNMTSPRSNAG

IVNS1ABP

586

Q9Y6Y0
SRTPVLMNFMMRGSW

GHITM

146

Q9H3K2
LMNFMMRGSWVTIGV

GHITM

151

Q9H3K2
MAGMSQRPPSMYWCV

LRRK1

1

Q38SD2
GIPAEDMMWMPVFQE

GARIN4

186

Q8IYT1
DMMWMPVFQEDRRSL

GARIN4

191

Q8IYT1
WALGVLMYEMMAGQP

PRKCE

591

Q02156
GWMMMKDENIPGTVV

ATP9B

436

O43861
MWMAFAIDFPLPMAS

SPINK8

16

P0C7L1
CSWMFQPMNNSKMRE

BEND2

616

Q8NDZ0
GQWRDMMDYMLQGVA

CYP21A2

251

P08686
NDPDIEMAWAMRAMQ

PBDC1

31

Q9BVG4
GMMAGPMAAFKWQPT

GLYR1

191

Q49A26
VFLVVMFWTMMLNGP

HEATR6

761

Q6AI08
VPFMREMAGAWHMTV

PI4KA

1246

P42356
MMSTAPQPVWDIMFQ

GGA2

521

Q9UJY4
MGRRIQFPIEMSMPW

CYFIP2

656

Q96F07
KGESAMWRQRMQQMS

GOLGA2

401

Q08379
AAMAAGESMAQRMVW

REXO2

31

Q9Y3B8
PGDWMAMSMVQNRVF

DOCK2

986

Q92608
MMMRDCWHAVPSQRP

FGFR1

731

P11362
MNAMQRPVRPGMGWT

BCL9L

626

Q86UU0
MEFTAWMPNFPASMR

ALOX12B

586

O75342
DMAFPRMNNMSFWLL

MT-CO1

91

P00395
WMNGQSLPMTHRMQL

PSG11

181

Q9UQ72
PEMTHVQTQRPWMMF

SLC39A12

651

Q504Y0
QGRLELWVDMFPMDM

OTOF

1701

Q9HC10
NVSVIGWMVMMADDP

RALGPS2

516

Q86X27
PGMEQGRLQMWVDMF

FER1L6

1561

Q2WGJ9
MDMVSNQHPWFGMEQ

GLUL

121

P15104
IMNLTEFSMVDGMWQ

SPHKAP

1046

Q2M3C7
EWRMMKNRPFMGSIS

PIH1D1

161

Q9NWS0
KIPWNFQHMMMFSGL

SLC9A9

426

Q8IVB4
KMRGMQVINPMGWDA

LARS2

116

Q15031
KVPSWAMDMNVLMSA

NBEAL2

986

Q6ZNJ1
QHLASMGFDPRWLMM

PRRC2C

726

Q9Y520
MGFDPRWLMMQSYMD

PRRC2C

731

Q9Y520
ALNGMVEMMDRRPYW

IARS2

506

Q9NSE4
MPFSFMMGVEWQDSF

SLC28A3

491

Q9HAS3
MMGVEWQDSFMVARL

SLC28A3

496

Q9HAS3
MSFLQDPSFFTMGMW

PRXL2A

1

Q9BRX8
MMPWQGDTNNMIDRF

CLASRP

66

Q8N2M8
RMQAFEASPMWLQDM

VSTM2A

156

Q8TAG5
QMLGFDPRWMMMPSY

PRRC2B

666

Q5JSZ5
MPQMFWNAGCQMVAL

PLCB2

616

Q00722
MDQNGMTPLMWAAYR

ZDHHC17

186

Q8IUH5
KQTWMDNMGRAGEME

TOP2A

191

P11388
MVMMWDLHGSSQPRQ

WDR31

126

Q8NA23